Ju-Wei R. Chang

Ju-Wei R. Chang

Auto-generated profile, based on publicly available information

Ju-Wei R. Chang

Medical Research Council

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
JCJu-Wei R. Chang
Ju-Wei R. Chang
FAFatai M. Akemokwe
Fatai M. Akemokwe
DMDiana M. Marangu
Diana M. Marangu
BCBlessings Chisunkha
Blessings Chisunkha
EIEshiobo Irekpita
Eshiobo Irekpita
Charles Owuora ObonyoCharles Owuora Obonyo
Charles Owuora Obonyo
Rationale: Obstructive sleep apnea (OSA) is a significant health problem among adults and children globally, resulting in decreased quality of life and increased costs of healthcare. For optimal clinical care, primary care physicians should be familiar with OSA and confident in their ability to screen, diagnose, and manage this condition. Objectives: To assess the knowledge, attitudes, and practices of primary care physicians in Kenya, Nigeria, and South Africa regarding OSA in adults and children. Methods: We conducted a multicenter cross-sectional survey in Kenya (Nairobi), Nigeria (Edo State), and South Africa (Cape Town) between April 2016 and July 2017. At least 40 participants were randomly selected from a register of primary care physicians at each site. Potential participants were contacted to receive online/paper-based, validated OSA Knowledge and Attitudes (OSAKA) and OSAKA in Children (OSAKA-KIDS) questionnaires related to adults and children, respectively. The median percentage knowledge scores and proportions of favorable attitude were computed and current diagnostic and referral practices were documented. Results: The median OSAKA knowledge scores were 83.3% (interquartile range [IQR], 77.8–88.9), 66.7% (IQR, 55.6–77.8), and 61.1% (IQR, 55.6–77.8) among South African, Kenyan, and Nigerian physicians, respectively. For OSAKA-KIDS, the median knowledge scores were 61.1% (IQR, 50.0–72.2), 64.2% (IQR, 35.3–93.2), and 58.3% (IQR, 44.4–66.7) among South African, Kenyan, and Nigerian physicians, respectively. Most physicians (90–94%) considered adult and pediatric OSA very/extremely important. Fewer physicians agreed/strongly agreed that they were confident about OSA diagnosis (55%), management (25%), and continuous positive airway pressure (18%) use in adults. Even fewer physicians agreed/strongly agreed that they were confident about pediatric OSA diagnosis (35%), management (21%), and continuous positive airway pressure use (18%). South African physicians mainly prescribed polysomnography (51%) and overnight oximetry (22%), whereas 49% of Nigerian physicians and 65% of Kenyan physicians commonly requested lateral cervical radiography. Conclusions: Primary care physicians in South Africa, Nigeria, and Kenya considered OSA to be important but had modest knowledge about OSA in adults and children, and had a low perceived confidence in adult and pediatric management. Focused educational interventions during undergraduate training and continuing professional development programs may improve primary physicians’ knowledge about OSA and its diagnosis and management.

1 January 2020 in Wits Journal of Clinical Medicine
Verified
Journal Article
Open access
KDKeertan Dheda
Keertan Dheda
MDMalika Davids
Malika Davids
JCJu-Wei Chang
Ju-Wei Chang
PGPhindile Gina
Phindile Gina
APAnil Pooran
Anil Pooran
SJShameem Jaumdally
Shameem Jaumdally
Coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 is a global pandemic that has resulted in over 1.5 million confirmed cases and close to 100,000 deaths. In the majority of symptomatic cases COVID-19 results in a mild disease predominantly characterised by upper respiratory tract symptoms. Reverse transcription polymerase chain reaction (RT-PCR), using a nasopharyngeal sample, is the mainstay of diagnosis, but there is an ~30% false negative rate early in the disease and in patients with mild disease. RT-PCR positivity can persist for several days after a resolution of symptoms. IgM and IgG antibody responses become positive several days after the onset of symptoms, and robust antibody responses are detectable in the second week of illness. Antibody-based immunoassays have a limited role in the diagnosis of early symptomatic disease. However, their incremental benefit over RT-PCR in the first 2 weeks of illness is currently being clarified in ongoing studies. Such assays may be useful for surveillance purposes. However, their role in potentially selecting individuals that may benefit from vaccination, or as a biomarker identifying persons that could be redeployed into essential employment roles are being investigated. Rapid antibody-based immunoassays that detect viral antigen in nasopharyngeal samples are being developed and evaluated.